Investment and M&A transaction comps
CPG Investment & M&A Transaction Comps
Global CPG and consumer brand investments, capital raises and M&A transactions, including food, beverage, beauty, personal care, supplements and adjacent branded consumer categories.
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 50 | 21 | 4.1x | 9.9x |
| 2025 | 28 | 26 | 3.3x | 12.9x |
| 2024 | 24 | 23 | 3.1x | 16.0x |
| 2023 | 31 | 26 | 3.9x | 20.4x |
| 2022 | 26 | 17 | 3.6x | 20.4x |
| 2021 | 47 | 37 | 4.4x | 15.0x |
| 2020 | 34 | 25 | 4.5x | 14.7x |
| 2019 | 17 | 15 | 3.6x | 17.4x |
Sortable transaction comps
CPG transaction table
Rows with reported value
7 / 8
Acquisition EV, USD
USD 21B
Investment EV, USD
USD 36B
Median EV / revenue
3.4x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
8 shown of 8 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately, and a financing without a reported valuation shows its amount raised, not an EV.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Skechers Control | 2025-05-05 | 3G Capital | USD 9.4B Transaction Value | 9,420 | 1.0x | - | Global | Confirmed 4 sources | ||
| ChapStick Control | 2024-01-25 | Suave Brands Company | USD 510M Consideration | 510 | 3.6x | - | Global | Estimated 2 sources | ||
| Reebok International Control (100%) | 2021-08-12 | Authentic Brands Group | EUR 2.1B Consideration | 2,465 | 1.5x | - | Global | Estimated 1 source | ||
| Valagro Control (10%) | 2020-10-06 | Syngenta Group | Undisclosed Undisclosed | Undisclosed | 3.4x | 17.5x | Global | Confirmed 1 source | ||
| Wella Company (Coty Professional and Retail Hair) Control (60%) | 2020-05-11 | KKR & Co. Inc. | USD 4.3B Enterprise Value | 4,300 | 1.8x | 12.3x | Global | Confirmed 1 source | ||
| 2018-05-07 | Nestlé S.A. | USD 7.2B Consideration | 7,150 | 3.6x | - | Global | Confirmed 1 source | |||
| GSK Consumer Healthcare (Novartis 36.5% stake) Minority (37%) | 2018-03-27 | GlaxoSmithKline | USD 36B Estimated Enterprise Value | 35,616 | 3.6x | 20.1x | Global | Estimated 1 source | ||
| RB Foods Control | 2017-08-17 | McCormick & Company, Incorporated | USD 4.2B Enterprise Value | 4,200 | - | - | global | Confirmed 19 sources |